TELA
Tela Bio IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$44.25M
P/E Ratio
—
EPS
$-0.83
Beta
0.99
52W High
$2.20
52W Low
$0.50
50-Day MA
$0.73
200-Day MA
$1.20
Dividend Yield
—
Profit Margin
-48.40%
Forward P/E
—
PEG Ratio
—
About Tela Bio Inc
TELA Bio, Inc., a medical technology company, focuses on the design, development and commercialization of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | $80.28M |
| Gross Profit (TTM) | $54.72M |
| EBITDA | $-32.74M |
| Operating Margin | -31.90% |
| Return on Equity | -223.30% |
| Return on Assets | -25.10% |
| Revenue/Share (TTM) | $1.71 |
| Book Value | $0.14 |
| Price-to-Book | 7.05 |
| Price-to-Sales (TTM) | 0.55 |
| EV/Revenue | 0.621 |
| EV/EBITDA | -5.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.20% |
| Shares Outstanding | $44.74M |
| Float | $19.47M |
| % Insiders | 8.42% |
| % Institutions | 70.59% |
Historical Volatility
HV 10-Day
124.94%
HV 20-Day
115.99%
HV 30-Day
130.70%
HV 60-Day
106.69%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($2.25 target)
1
Strong Buy3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/2/2026